Tenet Healthcare Corporation is projected to rise to $296.39 by 2027, a +17% move from its current price of $252.73. THC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $245.35 | $252.80 | $260.48 | +0.03% |
| Aug 2 | $242.40 | $252.87 | $263.80 | +0.06% |
| Aug 3 | $240.17 | $252.94 | $266.39 | +0.08% |
| Aug 4 | $238.32 | $253.01 | $268.61 | +0.11% |
| Aug 5 | $236.71 | $253.08 | $270.59 | +0.14% |
| Aug 6 | $235.27 | $253.15 | $272.40 | +0.17% |
| Aug 7 | $233.96 | $253.23 | $274.08 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $233.96 | $253.23 | $274.08 | +0.20% |
| Week 2 | $226.86 | $253.72 | $283.76 | +0.39% |
| Week 3 | $221.66 | $254.22 | $291.56 | +0.59% |
| Week 4 | $217.43 | $254.72 | $298.39 | +0.79% |
| Week 5 | $213.83 | $255.21 | $304.62 | +0.98% |
| Week 6 | $210.66 | $255.71 | $310.41 | +1.18% |
| Week 7 | $207.82 | $256.22 | $315.89 | +1.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenet Healthcare Corporation is a diversified healthcare services company operating in the United States. It operates through two segments: Hospital Operations and Services, and Ambulatory Care, delivering a broad range of inpatient and outpatient services, imaging, laboratories, and telemedicine access. Tenet was founded in 1967 and is headquartered in Dallas, Texas.
The company runs acute care and specialty hospitals, off campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. It provides procedures and services across orthopedics, cardiology, gastroenterology, pain management, otolaryngology, ophthalmology, urology, and related fields. This framing places Tenet as a large US health care services network with extensive hospital and ambulatory care assets and a long established presence in the sector.
Tenet Healthcare Corporation (THC) is currently priced at $262.63 with a market capitalization of $22.62B and a market ranking of 540. The current price and market position anchor the near term view as reflected in the year by year forecast. The forecast shows a range of possible outcomes with varied sentiment from neutral to bullish across the horizon.
The 2026 forecast holds an average price of $262.63 with a min of $161.37 and a max of $345.35, yielding a 0% ROI and a neutral sentiment. From 2027 onward the averages rise, with 2028 at $323.20, 2029 at $403.68, and a 2030 average of $489.21, supported by a bullish trajectory through the 2030s and beyond. Overall, the forecast projects rising averages and substantial upside over time, culminating in an average of $2,281.19 by 2050 with a 768.6% ROI.
A major floor 44.9% below — a decisive break under it would weaken the trend.
The nearest floor, 31.7% below — buyers have tended to step in here.
The nearest ceiling, 3.9% above — a clean break opens room to run.
A major ceiling 26.4% above — clearing it would confirm fresh momentum.
Key THC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of THC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $249.91 | Buy | $245.69 | Buy |
| MA 10 | $222.97 | Buy | $231.43 | Buy |
| MA 20 | $211.79 | Buy | $216.38 | Buy |
| MA 50 | $190.62 | Buy | $201.09 | Buy |
| MA 100 | $193.97 | Buy | $197.21 | Buy |
| MA 200 | $200.07 | Buy | $193.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.02 | Sell |
| Stoch RSI (14) | 78.43 | Neutral |
| CCI (20) | 143.20 | Buy |
| Williams %R (14) | -12.54 | Info |
| MACD (12,26,9) | 6.26 | Buy |
| ROC (12) | 37.59 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 87.46 | Sell |
| TRIX (15) | 0.75 | Buy |
| Awesome (5,34) | 50.55 | Buy |
| Ultimate (7,14,28) | 79.65 | Sell |
| Momentum (10) | 53.53 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 271.46 | Sell |
| ADX (14) | 27.85 | Buy |
| ATR (14) | 7.08 | Info |
The 30-day technical picture is bullish with a high level of momentum. The RSI14 is listed as 80, and the simple moving averages show SMA50 at $186.17 and SMA200 at $198.99. Key levels include a support at $172.57 and a resistance at $243.36.
The 30-day range spans from a low of $218.78 to a high of $315.27, and annualized volatility is 50%. These indicators suggest upside potential in the near term while highlighting upside and downside risks consistent with the breadth of the 30-day trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $161.37 | $252.73 | $338.54 | 0% | Neutral | |
| $234.30 | $296.39 | $397.65 | +17% | Neutral | |
| $253.27 | $330.54 | $461.85 | +31% | Bullish | |
| $322.68 | $432.17 | $623.18 | +71% | Bullish | |
| $388.62 | $532.51 | $788.38 | +111% | Bullish | |
| $404.48 | $565.91 | $857.29 | +124% | Bullish | |
| $440.90 | $628.96 | $972.56 | +149% | Bullish | |
| $451.78 | $656.35 | $1,033.93 | +160% | Bullish | |
| $473.39 | $699.79 | $1,121.30 | +177% | Bullish | |
| $557.18 | $837.46 | $1,363.26 | +231% | Bullish | |
| $759.17 | $1,230.94 | $2,140.46 | +387% | Bullish | |
| $1,568.61 | $2,902.46 | $5,553.20 | +10.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $161.37 | $252.73 | $295.17 | +0.00% |
| August 2026 | $222.16 | $261.26 | $314.81 | +3.38% |
| September 2026 | $218.44 | $259.26 | $316.98 | -0.77% |
| October 2026 | $215.67 | $257.86 | $318.92 | -0.54% |
| November 2026 | $221.46 | $266.39 | $332.55 | +3.31% |
| December 2026 | $222.33 | $268.92 | $338.54 | +0.95% |
Click any year to see its month-by-month THC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Tenet Healthcare Corporation's 2026 outlook centres on $252.73, within a $161.37 to $338.54 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, THC could reach as high as $397.65, with a base case around $296.39 and support toward $234.30 — roughly +17% from $252.73. A consolidation phase looks the most probable path here.
Expect THC to range from $253.27 to $461.85 through 2028. The $330.54 average target implies a +31% move from current prices. That is up +12% on the projected 2027 average. Momentum favours further upside here.
The THC price prediction for 2029 points to an average of $432.17 (low $322.68, high $623.18) — a potential gain of +71% on today's $252.73. Buyers look set to stay in control over this stretch.
In 2030, THC is projected to trade between $388.62 and $788.38, averaging $532.51 — a potential gain of +111% from today's $252.73. That is up +23% on the projected 2029 average. Momentum favours further upside here.
Tenet Healthcare Corporation's 2031 outlook centres on $565.91, within a $404.48 to $857.29 range. That is up +6% on the projected 2030 average. That marks a +124% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, THC could reach as high as $972.56, with a base case around $628.96 and support toward $440.90 — roughly +149% from $252.73. Momentum favours further upside here.
Expect THC to range from $451.78 to $1,033.93 through 2033. The $656.35 average target implies a +160% move from current prices. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The THC price prediction for 2034 points to an average of $699.79 (low $473.39, high $1,121.30) — a potential gain of +177% on today's $252.73. Momentum favours further upside here.
In 2035, THC is projected to trade between $557.18 and $1,363.26, averaging $837.46 — a potential gain of +231% from today's $252.73. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Tenet Healthcare Corporation's 2040 outlook centres on $1,230.94, within a $759.17 to $2,140.46 range. That is up +47% on the projected 2035 average. That marks a +387% change versus current levels. Momentum favours further upside here.
By 2050, THC could reach as high as $5,553.20, with a base case around $2,902.46 and support toward $1,568.61 — roughly +10.5x from $252.73. Buyers look set to stay in control over this stretch.
Investing $1,000 in THC today (≈ 3.956792 THC) could be worth
$11,484.44
+$10,484.44 (+1048%) by 2050 · US Dollar
Based on the average projected THC price of $2,902.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in THCwould be worth at today's price.
$1,000 invested in THC on Jul 30, 2025 (≈ 6.215427 THC) would be worth
$1,570.82
+$570.82 (+57.1%) today · 1.57× · US Dollar
Based on a THC entry price of $160.89 vs. today's $252.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $199.02 | $1,269.87 | +27.0% |
| 1 month ago | $187.08 | $1,350.92 | +35.1% |
| 3 months ago | $183.27 | $1,379 | +37.9% |
| 6 months ago | $189.28 | $1,335.22 | +33.5% |
| 1 year ago | $160.89 | $1,570.82 | +57.1% |
| All time (5.0y) ago | $71.21 | $3,549.08 | +254.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our THC forecast.
Our base-case forecast reaches $510.00 around 2030.
Implied market cap at $510.00: $41.06B
The multi year forecast depicts a clear path of rising averages and strong upside for Tenet through 2035, then into the 2040s and 2050. In 2030 the average price is $489.21 with a 86.3% ROI and a bullish sentiment. By 2040 the average rises to $1,023.77 with a 289.8% ROI, still supported by a bullish stance.
By 2050 the average is $2,281.19 with a 768.6% ROI and a bullish sentiment. The forecast implies continued bullish momentum across the long horizon, with higher max prices expected (for example, a max of $712.84 in 2030 and up to $4,238.47 by 2050). These figures reflect upside potential but are estimates, not guarantees, and should be weighed against individual risk tolerance.
Lower entries and macro uncertainty can temper the realized returns.
Tap a question to reveal the answer.
The 2030 forecast shows min $362.01, avg $489.21, max $712.84 with ROI 86.3% and sentiment BULLISH.
The forecast includes bullish sentiment from 2028 onward and a potential ROI up to 768.6% by 2050, though these are estimates and not guarantees.
Yes. The max forecast by 2035 is $1,135.88 and by 2040 is $1,736.78, indicating the possibility of passing the $1,000 level in the forecast horizon.
Current price is $262.63 and market cap is $22.62B, with a rank of 540.
RSI14 is 80; SMA50 is $186.17 and SMA200 is $198.99. Support is $172.57 and resistance is $243.36. The 30-day range is $218.78 to $315.27, with annualized volatility of 50%.
Tenet Healthcare Corporation Community Discussion
0Share your Tenet Healthcare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.